Bolstered by the support of more than $30 million, researchers at the MGH are now teaming up with colleagues at Brigham and Women’s Hospital and the German pharmaceutical company Bayer AG to study new drug options for chronic lung diseases.
Chronic Lung Disease (Bronchopulmonary Dysplasia)
Featured Treatment Areas
The Division of Pediatric Pulmonary Medicine is a well-established clinical, training and research program. The group provides multidisciplinary comprehensive consultation, diagnostic and management services.
News & Publications
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.